Prognostic significance of sarcopenia as determined by bioelectrical impedance analysis in patients with advanced pancreatic cancer receiving gemcitabine plus nab-paclitaxel: A retrospective study

Sarcopenia often affects patients with various types of cancer, and has been reported to affect patient prognosis and therapeutic effects. However, to the best of our knowledge, there are no reports on the relationship between gemcitabine plus nab-paclitaxel combination therapy (GnP) and sarcopenia...

Descripción completa

Detalles Bibliográficos
Autores principales: Tozuka, Yuichiro, Ueno, Makoto, Kobayashi, Satoshi, Morimoto, Manabu, Fukushima, Taito, Sano, Yusuke, Kawano, Kuniyuki, Hanaoka, Akane, Tezuka, Shun, Asama, Hiroyuki, Moriya, Satoshi, Morinaga, Soichiro, Ohkawa, Shinichi, Maeda, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494620/
https://www.ncbi.nlm.nih.gov/pubmed/36238838
http://dx.doi.org/10.3892/ol.2022.13495

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9494620/
https://www.ncbi.nlm.nih.gov/pubmed/36238838
http://dx.doi.org/10.3892/ol.2022.13495

Ejemplares similares